Key Details
Price
$13.80Annual EPS
-$10.55Annual ROE
-558.03%Beta
0.88Events Calendar
Next earnings date:
June 17, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 27, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Aug 28, 2024Analyst ratings
Recent major analysts updates
16 Aug '22 Chardan Capital
Neutral13 Dec '21 Chardan Capital
Neutral23 Nov '21 Chardan Capital
Buy17 May '21 HC Wainwright & Co.
Buy18 Dec '20 BMO Capital
Outperform17 Sept '20 Chardan Capital
Buy20 Nov '19 Guggenheim
Buy06 Nov '19 H.C. Wainwright
Buy26 Mar '19 Chardan Capital
Buy11 July '18 Ladenburg Thalmann
BuyScreeners with XCUR included
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Exicure doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
XCUR
businesswire.com26 December 2024
CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Partners with GPCR Therapeutics Inc. to Fuel New Growth in Biotech.
CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
XCUR
businesswire.com21 December 2024
CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes.
Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes
XCUR
businesswire.com20 December 2024
CHICAGO--(BUSINESS WIRE)--Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes.
Why Is Exicure (XCUR) Stock Down 27% Today?
XCUR
investorplace.com22 July 2024
Exicure (NASDAQ: XCUR ) stock is dropping on Monday after the prior early-stage pharmaceutical company's shares underwent a rally on Friday. That rally resulted in shares of XCUR stock rising 76% higher during normal trading hours.
Why Is Exicure (XCUR) Stock Up 57% Today?
XCUR
InvestorPlace08 December 2023
Exicure (NASDAQ: XCUR ) stock is rising higher on Friday despite a lack of news from the early-stage biotechnology company. Exicure hasn't released any recent press releases or made any filings that would result in today's stock rally.
FAQ
- What is the primary business of Exicure?
- What is the ticker symbol for Exicure?
- Does Exicure pay dividends?
- What sector is Exicure in?
- What industry is Exicure in?
- What country is Exicure based in?
- When did Exicure go public?
- Is Exicure in the S&P 500?
- Is Exicure in the NASDAQ 100?
- Is Exicure in the Dow Jones?
- When was Exicure's last earnings report?
- When does Exicure report earnings?
- Should I buy Exicure stock now?
What is the primary business of Exicure?
Exicure (XCUR) is a biotechnology company focused on developing innovative therapies using its unique DNA-based technology. They aim to treat various diseases, including genetic disorders and cancer, by delivering targeted treatments that can improve patient outcomes and enhance the effectiveness of existing therapies.
What is the ticker symbol for Exicure?
The ticker symbol for Exicure is NASDAQ:XCUR
Does Exicure pay dividends?
No, Exicure does not pay dividends
What sector is Exicure in?
Exicure is in the Healthcare sector
What industry is Exicure in?
Exicure is in the Biotechnology industry
What country is Exicure based in?
Exicure is headquartered in United States
When did Exicure go public?
Exicure's initial public offering (IPO) was on 22 May 2018
Is Exicure in the S&P 500?
No, Exicure is not included in the S&P 500 index
Is Exicure in the NASDAQ 100?
No, Exicure is not included in the NASDAQ 100 index
Is Exicure in the Dow Jones?
No, Exicure is not included in the Dow Jones index
When was Exicure's last earnings report?
Exicure's most recent earnings report was on 14 November 2024
When does Exicure report earnings?
The next expected earnings date for Exicure is 17 June 2025
Should I buy Exicure stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions